261 related articles for article (PubMed ID: 8056133)
1. Insulin-like growth factor I signalling through heterodimers of insulin and insulin-like growth factor I receptors.
Takata Y; Kobayashi M
Diabete Metab; 1994; 20(1):31-6. PubMed ID: 8056133
[TBL] [Abstract][Full Text] [Related]
2. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines.
Freund GG; Kulas DT; Way BA; Mooney RA
Cancer Res; 1994 Jun; 54(12):3179-85. PubMed ID: 8205537
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor II binding and action in human fetal fibroblasts.
Conover CA; Rosenfeld RG; Hintz RL
J Cell Physiol; 1987 Dec; 133(3):560-6. PubMed ID: 2961773
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical biological effects of overexpressed insulin-like growth factor-1 receptors in Chinese hamster ovary cells.
Kato H; Faria TN; Stannard B; Levy-Toledano R; Taylor SI; Roberts CT; LeRoith D
J Cell Physiol; 1993 Jul; 156(1):145-52. PubMed ID: 7686165
[TBL] [Abstract][Full Text] [Related]
5. Molecular dynamics of insulin/IGF-I receptor transmembrane signaling.
Pessin JE; Frattali AL
Mol Reprod Dev; 1993 Aug; 35(4):339-44; discussion 344-5. PubMed ID: 8398111
[TBL] [Abstract][Full Text] [Related]
6. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.
Dews M; Nishimoto I; Baserga R
Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824
[TBL] [Abstract][Full Text] [Related]
7. Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling.
Pandini G; Vigneri R; Costantino A; Frasca F; Ippolito A; Fujita-Yamaguchi Y; Siddle K; Goldfine ID; Belfiore A
Clin Cancer Res; 1999 Jul; 5(7):1935-44. PubMed ID: 10430101
[TBL] [Abstract][Full Text] [Related]
8. Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells.
Scott CD; Weiss J
J Cell Physiol; 2000 Jan; 182(1):62-8. PubMed ID: 10567917
[TBL] [Abstract][Full Text] [Related]
9. A functional assessment of insulin/insulin-like growth factor-I hybrid receptors.
Seely BL; Reichart DR; Takata Y; Yip C; Olefsky JM
Endocrinology; 1995 Apr; 136(4):1635-41. PubMed ID: 7895674
[TBL] [Abstract][Full Text] [Related]
10. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
11. Insulin and insulin-like growth factor-I receptors similarly stimulate deoxyribonucleic acid synthesis despite differences in cellular protein tyrosine phosphorylation.
Mastick CC; Kato H; Roberts CT; LeRoith D; Saltiel AR
Endocrinology; 1994 Jul; 135(1):214-22. PubMed ID: 7516864
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of glucocorticoids on insulin-like growth factor I action in cultured human fibroblasts.
Conover CA; Hintz RL; Johnson BF
J Cell Physiol; 1995 Jun; 163(3):615-22. PubMed ID: 7775603
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor.
Hongo A; D'Ambrosio C; Miura M; Morrione A; Baserga R
Oncogene; 1996 Mar; 12(6):1231-8. PubMed ID: 8649825
[TBL] [Abstract][Full Text] [Related]
14. Differential phosphorylation of pp120 by insulin and insulin-like growth factor-1 receptors: role for the C-terminal domain of the beta-subunit.
Najjar SM; Blakesley VA; Li Calzi S; Kato H; LeRoith D; Choice CV
Biochemistry; 1997 Jun; 36(22):6827-34. PubMed ID: 9184166
[TBL] [Abstract][Full Text] [Related]
15. Intracellular transactivation of the insulin-like growth factor I receptor by an epidermal growth factor receptor.
Burgaud JL; Baserga R
Exp Cell Res; 1996 Mar; 223(2):412-9. PubMed ID: 8601418
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871.
Cohen BD; Baker DA; Soderstrom C; Tkalcevic G; Rossi AM; Miller PE; Tengowski MW; Wang F; Gualberto A; Beebe JS; Moyer JD
Clin Cancer Res; 2005 Mar; 11(5):2063-73. PubMed ID: 15756033
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor I induction of c-myc expression in bovine fibroblasts can be blocked by antecedent insulin receptor activation.
Conover CA; Bale LK
Exp Cell Res; 1998 Jan; 238(1):122-7. PubMed ID: 9457064
[TBL] [Abstract][Full Text] [Related]
18. IGF-I receptor signalling: lessons from the somatotroph.
Melmed S; Yamashita S; Yamasaki H; Fagin J; Namba H; Yamamoto H; Weber M; Morita S; Webster J; Prager D
Recent Prog Horm Res; 1996; 51():189-215; discussion 215-6. PubMed ID: 8701079
[TBL] [Abstract][Full Text] [Related]
19. Effect of a mutation at tyrosine 950 of the insulin-like growth factor I receptor on the growth and transformation of cells.
Miura M; Li S; Baserga R
Cancer Res; 1995 Feb; 55(3):663-7. PubMed ID: 7834637
[TBL] [Abstract][Full Text] [Related]
20. Insulin and IGF-I action on insulin receptors, IGF-I receptors, and hybrid insulin/IGF-I receptors in vascular smooth muscle cells.
Johansson GS; Arnqvist HJ
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1124-30. PubMed ID: 16803852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
